Planning for preparedness: EU perspectives on Avian Influenza,

African Swine Fever and Lumpy Skin Disease

Workshop "Emergency preparedness for trans-boundary animal diseases":

the role of stakeholders 16 May 2017

Andrea Gavinelli, Head of Unit SANTE G3

"Official Controls and eradication of diseases in animals"

Outline

Instruments to plan EU actions and resources

in crisis preparedness:

• Animal Health Law

• Official Controls Regulation

• Financial framework: the Veterinary

programme

Challenges in 2017

African Swine F.

Av. flu

Lumpy Skin Disease

DG SANTE priorities on animal health policy

The EU animal disease management in practice:

1.An efficient network of MS CVOs and SANTE to ensure rapid exchange of information on disease outbreaks including ADNS;

2.Commission use of its powers and adopts emergency measures within few hours resulting in:

• fewer animals being killed less EU compensation being paid

• Member States not adopting unilateral measures ensuring:a) Functioning of EU single market

b) Solidarity between Member States c) Exports to 3rd Countries

DG SANTE priorities on animal health policy

The new Animal Health Law:

1. Puts emphasis on increased effort to anticipate possible outbreaks of new or exotic diseases in the EU

2. Provides even more solid foundation to ensure that the high levels of protection in the EU

3. EC to deliver on the objectives of this Law:

• simpler and clearer rules focus on key priorities: preventing and eradicating disease with prioritization by listing and categorizing diseases

• modern technologies: for surveillance and early detection, electronic identification and it is even more aligned with international standards

• more flexibility: to adjust rules to local circumstances, and to emerging issues such as climate and social change

SANTE policy addressing animal health challenges

The main challenge comes from the nature and scale of food and animal production systems entails inevitable outbreaks of disease which can escalate into crisis with important impacts on health, trade and the economy

- Old diseases: ASF (North East & South East)

- New/exotic diseases: LSD, PPR

- Emerging diseases: MERS CoV,

- Vector borne diseases: BT, WNV

- Wildlife driven disease: ASF, AI

- Aquatic new diseases: Acute hepatopancreaticnecrosis disease (of shrimps)

EU main tools for diseases control

• EU fully harmonised veterinary legislation

• Specific control Directive

• Contingency plans

• Regionalisation policy

• EU Reference Laboratory – diagnostic manual

• EU co-financing of emergency measures and eradication

programmes

• Enforcement – audits

• The Community Veterinary Emergency Team - CVET

• Better training for safer food – BTSF

• Scientific advise – EFSA scientific opinions

• International cooperation – OIE/FAO GF-TADSs

• EU research projects - RTD

By April 2018

The work over the next years: implementing AHL and OCR legislation

Animal Health

Law2016/429

Official Controls

Reg. 2017/625

drafting tertiary legislation

(delegated & implementing acts)

April 2021

14.12.2019

Set up the Reference Centre for Animal Welfare

No of empowermentslegally required and needed formarket functioning beforeapplication date (14.12.2019)

No of expected delegated &implementing acts:

No of empowerments:

A coordinated approach to implement new legislation

Animal Health Law

180

62

~16

OfficialControls

Regulation

85

37

~ 22

Veterinary programme in 2016: summary of allocation

Sampling0,41%

Testing48,42%

Slaughtering4,15%

Vaccination25,15%

Compensation18,01%

Cleaning desinfection

0,23%

Monitoring0,85%

Delivery of wild animals

0,02%

Other2,74%

Sampling 663.731,17 € 0,41%

Testing 77.680.381,65 € 48,42%

Slaughtering 6.658.530,90 € 4,15%

Vaccination 40.351.083,08 € 25,15%

Compensation 28.884.866,45 € 18,01%

Cleaning desinfection 369.478,95 € 0,23%

Monitoring 1.366.998,39 € 0,85%

Delivery of wild animals 39.864,63 € 0,02%

Other 4.402.680,08 € 2,74%

Total (in 2016) 160.417.615,29 € 100,00%

2016 Budget allocation per disease (Veterinary programmes)

African Swine Fever4,32% Avian Influenza In

Poultry And Wild Birds1,18%

Bluetongue In Endemic Or High Risk

Areas4,63%

Bovine Brucellosis6,41%

Bovine Tuberculosis

39,10%

Classical Swine Fever1,60%

Rabies16,43%

Salmonella10,77%

Sheep And Goat Brucellosis (B.

Melitensis)7,98%

Transmissible Spongiform

Encephalopathies7,57%

DISEASE amount of the Vet. Programme in 2016

African Swine Fever 6.935.966,52 €Avian Influenza In Poultry And Wild

Birds 1.879.274,04 €Bluetongue In Endemic Or High Risk

Areas 7.405.856,26 €

Bovine Brucellosis 10.290.515,67 €

Bovine Tuberculosis 62.753.327,85 €

Classical Swine Fever 2.571.002,93 €Rabies 26.371.318,83 €

Salmonella 17.274.846,85 €Sheep And Goat Brucellosis (B.

Melitensis) 12.803.137,75 €

Transmissible Spongiform Encephalopathies 12.132.368,60 €

Total 160.417.615,29 €

DISEASEINITIAL ALLOCATION -2017 Vet. Programme

African Swine Fever 9.638.000 € 6,43%

Avian Influenza 2.048.000 € 1,37%Bluetongue 7.997.000 € 5,34%

Bovine Brucellosis 9.556.000 € 6,38%

Bovine Tuberculosis 55.962.000 € 37,36%

Classical Swine Fever 1.967.000 € 1,31%

Rabies 24.955.000 € 16,66%Salmonella 18.954.000 € 12,65%

Sheep And Goat Brucellosis 9.383.000 € 6,26%

Transmissible Spongiform Encephalopathies

9.329.000 € 6,23%

total 149.789.000 100%

Avian influenza H5

Legislation on Regionalisation

• First Decision in relation to HPAI H5N8 in Hungary published on

10/11/2016.

• Decisions shall ensure transparency and safe trade between

disease free areas of Member States and to third countries.

• Establishing areas under restrictions at EU level aims at

preventing unnecessary disturbance to trade within the Union

and to avoid unjustified barriers to trade imposed by third

countries.

• Last consolidated version for all affected Member States and all

HPAI subtypes: Commission Implementing Decision (EU)

2017/247 + second amendment published on 24/03

African Swine Fever

2014 – 2017 ASF outbreaks (pigs) and notif. of cases (wild boar)(ADNS data from EE, LV, LT and PL)

0

50

100

150

200

250

300

350

Jan Feb May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb

2014 2015 2016 2017

11 African swine fever in domestic pigs

12 African swine fever in wild boar

ASF 2016/2017(ADNS & Empres-i data)

• No increased hunting with the purpose to reduce the wild boar population,

• Hunting should be conducted as such to avoid excessive movement of animals.

• Baiting is allowed (non-sustained feeding, limited food only for attracting wild boar for hunting).

• Sustained feeding (foraging) is forbidden.

Wild Boar as a risk for farmed pigs

Conclusions - ASF

• Current regionalisation proving to be effective to anticipate the spread of disease

• Seasonal pattern of the disease appear both in domestic and wild boars

• Need for good biosecurity

• Management of wild boar is a challenge that

involves all the actors (not only vets: hunters,

tourists…)

Lumpy skin disease

LSD zoning - COM. IMPLEMENTING DECISION (EU) 2016/2008

Free with Vaccination zone

Infected zone

LSD outbreaks 2015-Sep 2016 (ADNS)

Free zones with Vaccination (Part I): Croatia Bulgaria (certain areas

in the North and East part)

Infected zones (Part II): Continental Greece

(including the island of Limnos)

Bulgaria (excluding the ''free with vaccination'' zones

Bulgaria

Greece

Croatia

Commission support against Lumpy Skin Disease

EU LSD vaccine bank: 770.000 doses supplied, since its creation, April2016 (vaccine donations to various EU & non EU Member countries )

EU financial support

• EU Member countries: Compensation for stamping out

• EU & non EU Member countries: Compensation for the cost of LSDhomologous vaccines purchased and used through national procedures

Technical support: CVET (Community Veterinary Emergency Team)

+ 7 missions so far in various countries

Appointment of an EU Reference Laboratory (EURL) for Diseasescaused by Capripox viruses (including LSD) CODA – CERVA, Belgium,26 January 2017

International regional coordination for LSD (GF-TADS)

LSD in SE Europe: Priorities in 2017

All countries that vaccinated against LSD in 2016 to repeatvaccination in 2017 as soon as possible (preferably beforeApril 2017)

National vaccine procurements are in progress. EU to assistwith vaccines from EU LSD vaccine bank + financial support for thenational purchase of vaccines (GF TADs teleconference on23.02.2017).

Ongoing selection of the call for tenders (closed 10 April) forthe purchase of 2,34 million doses of vaccines for the EU LSDvaccine bank

Regional coordination (future GF-TADs meetings)

Thank you